Genetic Technologies
GENE
#11109
Rank
โ‚น0.34 B
Marketcap
โ‚น72.09
Share price
0.00%
Change (1 day)
-66.70%
Change (1 year)

EPS for Genetic Technologies (GENE)

EPS in 2018 (TTM): N/A

In 2023 the company made an earnings per share (EPS) of -โ‚น3.13 a decrease over its 2022 EPS that were of -โ‚น2.08.

EPS history for Genetic Technologies from 2001 to 2018

Annual EPS

Year EPS Change
2023-โ‚น3.1350.65%
2022-โ‚น2.08-99.04%
2021-โ‚น216.12-46.67%
2020-โ‚น405.23-99.38%
2019-โ‚น64,83710809.09%
2018-โ‚น594.34-41.07%
2017-โ‚น1,009-18.37%
2016-โ‚น1,236-40.24%
2015-โ‚น2,068-53.41%
2014-โ‚น4,438-10.66%
2013-โ‚น4,96771.3%
2012-โ‚น2,900-622.73%
2011โ‚น554.72-108.8%
2010-โ‚น6,304-3.92%
2009-โ‚น6,56173.47%
2008-โ‚น3,78224.96%
2007-โ‚น3,027-10.93%
2006-โ‚น3,398-48.62%
2005-โ‚น6,614-8.31%
2004-โ‚น7,213
2003N/A-100%
2002-โ‚น4,479-9.36%
2001-โ‚น4,941

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Thermo Fisher Scientific
TMO
โ‚น1,790N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น959.36N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
โ‚น576.75N/A๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚น1,156N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚น35.81N/A๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Neogen
NEOG
-โ‚น23.86N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-โ‚น128.17N/A๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚น2,760N/A๐Ÿ‡บ๐Ÿ‡ธ USA